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Recent work identified a high prevalence of modifiable risk factors for cardiovascular disease (CVD)
among urban black South Africans. The aim was to track the progression of CVD risk factors in a multi-
ethnic sample of South Africans. Participants were 173 black (aged 47.5 ± 7.8 yrs) and 186 white teachers
(aged 49.6 ± 9.9 yrs) that were examined at baseline and 3 years follow-up. Blacks demonstrated a
substantially higher prevalence of composite CVD burden (defined as history of physician diagnosed
heart disease, use of anti-hypertensives, anti-diabetic, or statin medications at either time point)
compared to whites (49.1 vs. 32.0%, p ¼ 0.012) respectively. After controlling for baseline, the black
participants demonstrated greater increases in 24 h systolic and diastolic blood pressure, total choles-
terol, fasting glucose, fibrinogen, D-dimer, and waist circumference in comparison with whites. In
summary, an adverse progression of CVD risk factors was observed in the whole sample, although to a
larger degree in black participants. Aggressive treatment strategies for controlling risk factors in black
Africans are needed to reduce the increasing burden of CVD in South Africa.
© 2014 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-
SA license (http://creativecommons.org/licenses/by-nc-sa/3.0/).1. Introduction
Recent work identified a high prevalence of modifiable risk
factors for cardiovascular disease (CVD) among urban black South
Africans [1,2]. Most estimates of CVD risk factor prevalence in South
Africa have been based on data collection at one point in time,
although reliable information about trajectories can help to assess
the implications of rising prevalence of CVD risk factors on popu-
lation health, set policy priorities, and evaluate their success.
Existing data on global trends between 1980 and 2008 has
shown increases in various CVD risk factors such as body mass
index, cholesterol and blood pressure [3e5], although substantial
differences across regions and sexes have been noted. At present
little longitudinal data exist on CVD risk factors in multi-ethnic
samples from South Africa.ogy and Public Health, 1-19
WC1E 6BT, UK.
Ireland Ltd. This is an open accessThe aim of the Sympathetic Activity and Ambulatory Blood
Pressure in Africans (SABPA) study was to create a unique, highly
phenotyped cohort of Africans in a well-controlled research setting
enabling us to track the progression of CVD risk factors [6]. Here we
present data from the 3-year follow up.2. Methods
The study sample comprised urban black and white teachers
from the North West Province, South Africa [6]. All teachers
(N ¼ 2170), enrolled in the 43 schools of the Dr Kenneth Kaunda
Education District (Klerksdorp and Potchefstroom), North-West
Province South Africa, were invited to participate. Exclusion
criteria included pregnancy or lactating women, individuals who
donated blood or had been vaccinated in the 3-months prior the
commencement of testing, as well as those with a tympanum
temperature greater than 37.5 C. At baseline, (2008/9) 409
teachers were recruited of which 359 attended the 3-year follow-
up. All participants provided written informed consent and thearticle under the CC BY-NC-SA license (http://creativecommons.org/licenses/by-nc-
Table 1
Comparison between white (reference group) and black participants of CVD risk
factor progression over a three-year follow-up period.
Risk factor Adjusted coefficient (95% CI) p-value
24 h systolic blood pressure 6.02 (3.51, 8.55) <0.001
24 h diastolic blood pressure 3.57 (1.96, 5.17) <0.001
CIMT 0.048 (0.033, 0.064) <0.001
Cross sectional wall area 1.27 (0.73, 1.81) <0.001
Endothelin-1 0.21 (0.99, 1.41) 0.73
HDL cholesterol 0.02 (0.08, 0.04) 0.50
Total cholesterol 0.65 (0.45, 0.86) <0.001
Total: HDL cholesterol ratio 0.86 (0.64, 1.08) <0.001
Triglycerides 0.26 (0.11,0.17) 0.72
Glycated haemoglobin 0.13 (0.05, 0.30) 0.16
Glucose 1.22 (0.91, 1.52) <0.001
Insulin 0.35 (0.94, 1.65) 0.59
Fibrinogen 0.55 (0.41, 0.69) <0.001
D-dimer 132.15 (31.36, 232.94) 0.01
Interleukin-6 1.48 (4.37, 1.42) 0.32
Tumour necrosis factor-a 0.57 (1.00, 0.14) 0.01
BMI 0.24 (0.73, 0.25) 0.33
Waist 1.92 (0.24, 3.59) 0.03
Coefficients reflect differences between white (ref) and black Africans, adjusted for
age, sex, serum cotinine, physical activity energy expenditure, history of CVD,
medication, and baseline levels of the respective risk factor. Where: CIMT, carotid
intima media thickness; HDL, high density lipoprotein; BMI, body mass index.
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University (Potchefstroom Campus).
The clinical assessment procedures have been described in
detail elsewhere [6]. On the morning prior to the clinical assess-
ment, 24-h ambulatory blood pressure monitoring (ABPM) was
conducted during the working day (Meditech CE120 CardioTens;
Meditech, Budapest, Hungary) on the non-dominant arm. All par-
ticipants attended the Metabolic Unit Research Facility of the
North-West University and were assessed in the morning after an
overnight stay. Basic anthropometric data, including height, body
mass and waist circumference, and fasting blood samples were
collected. Carotid intima media thickness (CIMT) was assessed us-
ing a SonoSite Micromaxx ultrasound system (SonoSite, Bothell,
WA) and a 6e13 MHz linear array transducer. The ABPM data was
analysed using the CardioVisions 1.15 Personal Edition software
(Meditech).
Plasma and serum from fasting blood samples were analysed
using two sequential multiple analyzers (Konelab 20i; Thermo
Scientific, Vantaa, Finland; Unicel DXC 800 - Beckman and Coulter®,
Germany), enzyme-linked immunosorbent assays (Quantikine
Enzyme linked immunosorbent assay, R&D Systems, Minneapolis,
MN USA), and viscosity-based clotting method (Immuno-turbi-
metric method 540 nm, STA Compact, STAGO Diagnostic).
Biochemical risk factors included endothelin-1, total and high
density lipoprotein (HDL), cholesterol, triglycerides, glycated hae-
moglobin, glucose, insulin, fibrinogen, D-dimer, interleukin-6, and
tumour necrosis factor-a. The intra- and inter-coefficients of vari-
ation for all assays were below 10%.
The distribution of all variables was tested for normality and
non-normally distributed variables were appropriately trans-
formed prior analyses. We used c2 tests to examine differences in
prevalence of medication use and history of CVD between blacks
and whites. General linear models were used to examine the dif-
ference in risk factors between black and white participants at
follow-up after controlling for baseline levels of the respective risk
factor. In addition, models were adjusted for age, sex, baseline
serum cotinine as an objective indicator of smoking, baseline
physical activity energy expenditure (24 h Actical accelerometer),
history of CVD, and baseline medication (anti-hypertensives, sta-
tins, antidiabetics). These co-variables were chosen a priori based
on associations with the exposure and the independent variables
[7]. All analyses were conducted using SPSS (version 20), and sta-
tistical significance was set at p < 0.05.
3. Results
At follow-up, 173 black (aged 47.5 ± 7.8 yrs) and 186 white
participants (aged 49.6 ± 9.9 yrs) attended the clinic (representing
86.5% and 89.1% of initial baseline sample, respectively). Reasons
for non-attendance at follow up included death (n ¼ 9), pregnancy
(n ¼ 1), lactating (n ¼ 1), withdrawal from study (n ¼ 39). Partici-
pants that withdrew (54% blacks) had similar prevalence of CVD at
baseline (14.0 vs. 10.3%, p ¼ 0.43), and did not differ in their re-
ported use of antihypertensive medication (16.0 vs. 24.5%, p ¼ 0.18)
compared to participants attending follow-up. They also did not
differ in relation to other risk factors such as total: HDL cholesterol
ratio (4.55 ± 1.94 vs. 4.77 ± 1.84, p ¼ 0.44) and glucose (5.32 ± 1.24
vs. 5.70 ± 1.58 mmol/l, p ¼ 0.11).
At baseline, physician diagnosed heart disease was prevalent in
9.0% and 11.4% of black and white participants respectively. Anti-
hypertensive medication was used in 36.6% of black participants
and 66.0% met criteria for hypertension based on 24hr ABPM
(>130/80 mmHg) [8] alone; in comparison only 13.5% of white
participants used anti-hypertensives and 39.2% were classified as
hypertensive based on ABPM alone. Statins were used in 1.0% and4.9% of black and whites, respectively, whereas anti-diabetic
medication was used in 5.0% and 1.0% respectively. At follow-up,
there was no difference in incident use (new users that did not
report being medicated at baseline) of anti-hypertensives between
black and white participants (9.8% vs. 11.8%, p ¼ 0.72); incident use
of statins was lower in blacks compared to whites (1.7% vs. 13.4%,
p ¼ 0.001); incident use of anti-diabetic medication was greater in
blacks compared with whites (10.4% vs. 4.8%, p ¼ 0.03). We calcu-
lated the accumulative prevalence of CVD burden, based on a
composite score comprising history of physician diagnosed heart
disease, use of anti-hypertensives, anti-diabetic, or statin medica-
tions at either time point. Blacks demonstrated a substantially
higher prevalence of composite CVD burden compared to whites
(49.1 vs. 32.0%, p ¼ 0.012).
The mean averages and standard errors for CVD risk factors at
baseline and follow up in blacks and whites are presented in
Table S1. After controlling for baseline, the black participants
demonstrated greater increases in 24 h systolic and diastolic blood
pressure, total cholesterol, glucose, fibrinogen, D-dimer, and waist
circumference in comparison with whites (see Table 1). In contrast,
whites demonstrated a greater increase in CIMT, cross sectional
wall area and tumour necrosis factor-a. Nevertheless, absolute
levels of tumour necrosis factor-a remained higher in blacks at
baseline and follow-up (Table S1).4. Discussion
The aim of this studywas to examine the progression of CVD risk
factors in a unique, highly phenotyped cohort of Africans. Previous
work has identified a high prevalence of modifiable risk factors
among urban black Africans [1,2], although we are not aware of any
longitudinal study that has examined trajectories in risk factors in
this population. Thus, this is one of the first studies to demonstrate
overall an adverse progression of risk factors over 3 years follow-up
in black South Africans compared with whites. The black partici-
pants also demonstrated a different pattern of medication use,
reporting greater use of anti-hypertensives and anti-diabetics, but
lower statin use than whites.
The current acculturation process in black Africans is charac-
terized by detrimental behavioural lifestyle factors such as
M. Hamer et al. / Atherosclerosis 238 (2015) 52e5454unhealthy dietary habits, sedentary behaviour, excess alcohol
intake and tobacco use that might partly explain the dramatic in-
crease in CVD. Differences in lifestyle risk factors between black and
white SABPA participants have been demonstrated at baseline [7],
and other work suggested smoking and waist circumference were
predictive of incident hypertension over 5 years follow up in black
Africans [9]. Although South Africa has seen an overall trend for
reduced smoking rates over the last 20 years, there is marked
heterogeneity. For example, lower socio-economic groups have
demonstrated an increasing trend for use of roll-your-own ciga-
rettes [10]. The present analyses were adjusted for objective mea-
sures of smoking and physical activity, thus adverse CVD risk might
also be explained by other variables, such as chronic stress expo-
sure [11].
Interestingly, white participants demonstrated greater increases
in CIMT than blacks despite higher reported usage of statin medi-
cation and lower total cholesterol levels. Albeit, similar prevalence
of CIMTstenosis was observed inwhites (26.0%) compared to blacks
(24.9%). This is partly consistent with previous findings where black
Africans were more likely to be diagnosed with symptomatic ce-
rebrovascular disease (hypertension, ischaemic heart disease and
diabetes) [12] consistent with the risk factors observed in the
present sample of black Africans.
Ethnic differences in coagulation are still poorly understood
with studies showing enhanced clotting but also increased
bleeding tendency in various clinical settings in Africans [13]. We
found greater increases in fibrinogen and D-dimer over follow-up
in blacks than whites, and this potential predisposition to low-
grade hypercoagulability might contribute to higher risk of athe-
rothrombotic CVD, including stroke.
The limitations of this study should be highlighted. Firstly, the
sample consisted of urban-dwelling teachers that may not be
representative of the South African population. Data on medication
and diagnosis of prevalent CVD were based on self report that
might have introduced bias.
In summary, there appears to be a worsening CVD risk profile in
both black and white participants over a 3-year period, although
there is a difference in the distribution of these markers. Overall,
there was a greater worsening/progression of CVD risk factors in
black compared to white participants. Aggressive treatment stra-
tegies for controlling CVD risk factors in black Africans are needed
to reduce the increasing burden of CVD in South Africa.Conflicts of interest
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